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Abstract
Rationale Dopamine D1 receptor (D1R) signalling is involved in contextual fear conditioning. The D1R antagonist SCH23390
impairs the acquisition of contextual fear when administered systemically or infused locally into the dorsal hippocampus or
basolateral amygdala.
Objectives We determined if state dependency may account for the impairment in contextual fear conditioning caused by
systemic SCH23390 administration. We also examined if the dorsomedial prefrontal cortex (dmPFC), nucleus accumbens
(NAc), and ventral hippocampus (VH) are involved in mediating the effect of systemic SCH23390 treatment on contextual fear
conditioning.
Methods In experiment 1, SCH23390 (0.1 mg/kg) or vehicle was given before contextual fear conditioning and/or retrieval. In
experiment 2, SCH23390 (2.5 μg/0.5 uL) or vehicle was infused locally into dmPFC, NAc, or VH before contextual fear
conditioning, and retrieval was tested drug-free. Freezing was quantified as a measure of contextual fear.
Results In experiment 1, SCH23390 given before conditioning or before both conditioning and retrieval decreased freezing at
retrieval, whereas SCH23390 given only before retrieval had no effect. In experiment 2, SCH23390 infused into dmPFC before
conditioning decreased freezing at retrieval, while infusion of SCH23390 into NAc or VH had no effect.
Conclusions The results of experiment 1 confirm those of previous studies indicating that D1Rs are required for the acquisition
but not retrieval of contextual fear and rule out state dependency as an explanation for these findings. Moreover, the results of
experiment 2 provide evidence that dmPFC is also part of the neural circuitry through which D1R signalling regulates contextual
fear conditioning.
Keywords Anterior cingulate cortex . Contextual fear . Dopamine . D1 receptor . Nucleus accumbens . Open field . Prefrontal
cortex . SCH23390 . Ventral hippocampus
Introduction
Dopamine is a neurotransmitter that is important for memory
processing and its role in mediating appetitive learning is well
established (Dalley and Everitt 2009). However, dopamine
transmission is also involved in various aspects of aversive
learning and memory (Pezze and Feldon 2004; Brandão
et al. 2015). During contextual fear conditioning, a novel con-
text is paired with an aversive unconditioned stimulus (US;
e.g., footshock). This leads to an association between the con-
text and US forming and, in turn, a fear response being elicited
in the context after conditioning. Dopamine D1-like receptor
(D1R) signalling has been linked to this type of aversive learn-
ing. Systemic D1R blockade with the selective antagonist
SCH23390 impairs contextual fear conditioning, as shown
by a decrease in freezing during later retrieval testing (Inoue
et al. 2000; Calzavara et al. 2009; Heath et al. 2015). In con-
trast, SCH23390 given immediately after conditioning or be-
fore retrieval has no effect on fear at retrieval (Inoue et al.
2000; Bai et al. 2009; Heath et al. 2015). These findings sug-
gest that D1R antagonism disrupts the acquisition but not the
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consolidation or retrieval of contextual fear, although it is
possible that the effect of SCH23390 on contextual fear con-
ditioning in these previous studies involved state dependency.
Memory retrieval can be enhanced when the internal state
during retrieval is similar to when the memory was originally
acquired (Overton 1964). However, previous reports of
SCH23390-induced impairment of the acquisition of contex-
tual fear did not address potential drug effects on state-
dependent learning given that retrieval was tested drug-free.
The neural substrates underpinning the effect of
SCH23390 on contextual fear conditioning also remain to be
fully elucidated. Heath et al. (2015) showed that SCH23390
impairs the acquisition of contextual fear when infused into
the dorsal hippocampus (DH) or basolateral amygdala (BLA).
These two brain regions are crucial for contextual fear condi-
tioning, with encoding of the contextual representation and
context-US association thought to be mediated by DH and
BLA, respectively (Anagnostaras et al. 2001). However,
D1Rs in other areas may also be involved in regulating con-
textual fear conditioning. DH and BLA are reciprocally con-
nected indirectly via the ventral hippocampus (VH) (Pitkanen
et al. 2000), which is crucial for regulating innate fear but is
also involved in spatial and contextual fear learning (Bast et al.
2001; Kjelstrup et al. 2002, 2008; Sutherland et al. 2008; Trent
andMenard 2010; Czerniawski et al. 2012; deHoz andMartin
2014; Zhang et al. 2001, 2014). VH receives dopamine input
and expresses D1Rs (Fremeau Jr et al. 1991; Gasbarri et al.
1994), suggesting that D1R signalling in this area might reg-
ulate contextual fear conditioning. The hippocampus and
BLA project to corticostriatal areas, such as the dorsomedial
prefrontal cortex (dmPFC) and the nucleus accumbens (NAc)
(McDonald 1991; Thierry et al. 2000), traditionally linked to
executive and motivational functions but which also form part
of the wider neural circuitry underlying contextual fear condi-
tioning (Haralambous and Westbrook 1999; Levita et al.
2002a; Thomas et al. 2002; Dalley et al. 2004; Cassaday
et al. 2005; Liljehom and O’Doherty 2012; Einarsson and
Nader 2012; Gilmartin et al. 2013; de Lima et al. 2018).
Both dmPFC and NAc receive dopaminergic projections,
and D1Rs are expressed in these regions (Oades and
Halliday 1987; Fremeau Jr et al. 1991). Moreover, dopamine
and D1Rs in these areas have been implicated in various con-
textual fear processes (Pezze et al. 2001, 2016; Martinez et al.
2008; Albrechet-Souza et al. 2013; Ikegami et al. 2014), al-
though it remains to be established if D1R signalling in
dmPFC and NAc is required for contextual fear conditioning.
In this study, we sought to confirm and extend previous
findings on the effects of SCH23390 on contextual fear con-
ditioning. In experiment 1, we determined the effects of sys-
temic SCH23390 administration on the acquisition and re-
trieval of contextual fear, and if any observed drug effects on
these processes reflected state dependency. In experiment 2,
we examined the effects of infusing SCH23390 locally into
the VH, dmPFC, or NAc on contextual fear conditioning. We
also assessed the effects of SCH23390 infusion into these
areas on behavior in the open-field test to confirm if D1Rs
in these areas are involved in mediating the impairing effect of
this drug on locomotor activity (Bruhwyler et al. 1991; Heath
et al. 2015). This has implications for interpreting any acute
drug effects on freezing during conditioning, given that
changes in locomotion may affect the expression of freezing.
Materials and methods
Animals
Male Lister Hooded rats (Charles River, UK) weighing 280–
390 g at the start of the experiment (experiment 1) or before
surgery (experiment 2) were used. Rats were group housed in
individually ventilated cages and kept on a 24-h light/dark
cycle (lights on at 07.00) with ad libitum access to food and
water. All behavioral testing occurred during the rats’ light
cycle. The principles of laboratory animal care were followed
and all experimental procedures were performed with institu-
tional ethical approval and under the UK Animals (Scientific
Procedures) Act 1986 (Home Office Project Licence 30/
3230).
Experiment 1
Drug injection
SCH23390 hydrochloride (0.1 mg/kg, i.p.; Tocris Bioscience,
UK) was dissolved in 0.9% sterile saline. This dose has pre-
viously been shown to disrupt contextual fear conditioning
(Inoue et al. 2000; Heath et al. 2015). Vehicle-treated controls
received injections of 0.9% sterile saline (1 mL/kg, i.p.).
Contextual fear conditioning and memory testing
The effects of systemic administration of SCH23390 on con-
textual fear learning and memory retrieval were investigated
using a 2-day paradigm (Fig. 1a). The apparatus used has been
described in detail elsewhere (Stevenson et al. 2009), and the
procedures used were modified from our previous studies
(Stevenson 2011; Heath et al. 2015). On day 1, rats were
conditioned in a novel context consisting of distinct visual
(stripes or spots on two walls of the chambers with the house
light on), auditory (60-dB white noise), and olfactory (40%
ethanol) cues present during conditioning. The US used was a
mild electric shock delivered automatically through the floor
bars of the chamber by a computer running MED-PC IV soft-
ware (Med Associates, VT). Rats were placed in one of the
four chambers and after 2 min received four unsignalled
shocks (0.5 mA, 0.5 s, 1-min inter-trial interval); rats were
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removed from the chamber 2 min after the last shock and
returned to the home cage. On day 2, rats were returned to
their conditioning chamber for 5 min to test retrieval. Rats
were randomly allocated to receive an injection of
SCH23390 or vehicle 30 min before conditioning and/or re-
trieval, resulting in the following treatment groups: (1) vehicle
given before conditioning and retrieval (VEH-VEH), (2) ve-
hicle given before conditioning and SCH23390 given before
retrieval (VEH-SCH), (3) SCH23390 given before condition-
ing and vehicle given before retrieval (SCH-VEH), and (4)
SCH23390 given before conditioning and retrieval (SCH-
SCH). Behavior on both days was recorded using a digital
camera (Viewpoint, France) positioned above the chamber.
The floor bars and waste tray were cleaned with 40% ethanol
between each session. Rats were tested at approximately the
same time of day (± 1 h) on both days.
Data analysis
Freezing was scored automatically using Videotrack Software
(Viewpoint). The freezing detection thresholdwas set to detect
the absence ofmovement apart from that related to respiration.
During conditioning, the cumulative duration of freezing dur-
ing the 2-min intervals before the first and after the last shock
was calculated and expressed as a percentage of both 2-min
durations. Differences in freezing before and after condition-
ing between the four groups were analyzed using a two-way
analysis of variance (ANOVA), with treatment as the
between-subject factor and time (i.e., before and after condi-
tioning) as the within-subject factor. Freezing during the
retrieval session was determined as above. Differences in
freezing during retrieval testing between the four groups were
analyzed in two ways. Freezing throughout the whole session
was analyzed using a one-way ANOVA, with treatment as the
between-subject factor. Freezing during each 1-min bin of the
session was also analyzed using a two-way ANOVA, with
treatment as the between-subject factor and time as the
within-subject factor. Post hoc analysis was conducted using
the Newman-Keuls test where indicated. The data are present-
ed in scatter plots, with the mean ± SEM indicated by hori-
zontal lines and error bars, respectively, or in line graphs as the
mean + SEM. The level of significance for all comparisons
was set at P < 0.05.
Experiment 2
Surgery
Anesthesia was induced with ~ 3% isoflurane in O2 and
an opioid analgesic (buprenorphine, 0.05 mg/kg, Richter
Pharma, Austria) was administered immediately post-in-
duction. Anesthesia was maintained during surgery with
1.5–2.5% isoflurane to ensure complete inhibition of the
hindpaw withdrawal reflex. Rats were placed in a stereo-
taxic frame and the incisor bar was adjusted to maintain
the skull horizontal. Rats were implanted bilaterally with
guide cannulae (26 gauge, PlasticsOne, VA) fitted with
obturators (33 gauge; PlasticsOne) targeting dmPFC
(2.7–3.0 mm anterior and 1.2 mm lateral (angled 12° from
the midline) to bregma, 2.0–2.3 mm ventral to the brain
Fig. 1 SCH23390 impairment of contextual fear conditioning is not
accounted for by state dependency. a Schematic representation of the
experimental design used. b SCH23390 injection before conditioning
(SCH-VEH and SCH-SCH) increased freezing before and after shock
presentations, compared to vehicle (VEH-VEH and VEH-SCH)
(P < 0.05). c There was no difference in freezing between the VEH-
VEH and VEH-SCH groups throughout retrieval, whereas freezing in
the SCH-VEH and SCH-SCH groups was decreased, compared to the
VEH-VEH and VEH-SCH groups (*P < 0.05). d The time course analy-
sis of freezing during retrieval also showed that freezing in the SCH-VEH
and SCH-SCH groups was decreased, compared to the VEH-VEH and
VEH-SCH groups (*P < 0.05)
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surface), NAc (1.2 mm anterior and 2.4 mm lateral (an-
gled 6° from the midline) to bregma, 6.5 mm ventral to
the brain surface), or VH (5.0 mm posterior and 4.8 mm
lateral to bregma, 6.3 mm ventral to the brain surface)
(Paxinos and Watson 2007). Cannulae were secured with
dental cement to 4–6 screws threaded into the skull. At
the end of surgery, a non-steroidal anti-inflammatory an-
algesic (Metacam, 1 mg/kg, Boehringer Ingelheim,
Germany) was administered. Rats were singly housed
for 1–2 days post-surgery to allow time to recover without
their cagemates being present and potentially interfering
with the wound or implant, after which they were group
housed as above. Buprenorphine and Metacam were given
for 2 days following surgery. Two days after surgery, rats
were mildly restrained and the obturators were replaced
with clean ones. On days 4 and 6 after surgery, the obtu-
rators were loosened and re-tightened. This ensured that
the cannulae remained unblocked after surgery and also
served to habituate the rats to handling for the local drug
infusion procedure (see below). Behavioral testing com-
menced 6–7 days after surgery.
Drug infusion
SCH23390 (2.5 μg) was dissolved in 0.5 μL of 0.9% sterile
saline. This dose has previously been shown to impair contex-
tual fear conditioning when infused locally into the BLA
(Heath et al. 2015). SCH23390 or vehicle (0.9% sterile saline)
was infused bilaterally into dmPFC, NAc, or VH in a volume
of 0.5 μL over 1 min using injector cannulae (33 gauge;
PlasticsOne) connected to 1 μL Hamilton syringes via poly-
ethylene tubing. The injector cannulae were left in place for
1 min following infusions to allow for drug diffusion and were
then removed and replaced with the obturators.
Contextual fear conditioning and memory testing
The effects of infusing SCH23390 into dmPFC, NAc, or
VH on contextual fear conditioning were investigated
using a 2-day testing paradigm (Fig. 3a). Rats were ran-
domly allocated to receive a local infusion of SCH23390
or vehicle 10 min before conditioning on day 1 and re-
trieval was tested drug-free on day 2. The apparatus and
procedures used were the same as above for experiment 1,
except that the US duration was extended to 1 s to miti-
gate any potential deficit in freezing caused by surgery
(Zhang et al. 2001; Hart et al. 2009; Heath et al. 2015).
Open-field testing
The same rats used in the contextual fear conditioning
experiment were used 2–4 days later for open-field test-
ing. The apparatus and testing procedures used have been
described in detail elsewhere (Heath et al. 2015). Rats
were randomly allocated to receive a local infusion of
SCH23390 or vehicle as described above. Open-field test-
ing, which commenced 10 min after drug infusion, lasted
for 10 min. Behavior was digitally recorded for subse-
quent data analysis.
Histology
Upon completion of open-field testing, rats were deeply anes-
thetizedwith sodium pentobarbital and perfused transcardially
with 0.9% saline followed by 4% paraformaldehyde. The
brains were removed, post-fixed in 4% paraformaldehyde,
and kept at 4 °C until slicing. The sections containing the
relevant areas were obtained and stained for acetylcholinester-
ase. Only data from rats with histologically confirmed cannula
placements bilaterally in dmPFC (prelimbic or rostral anterior
cingulate cortices), NAc (core or shell), and VH (CA1) were
included in the analysis (Fig. 2).
Data analysis
Freezing before the first and after the last shock presen-
tations during conditioning was quantified as above for
experiment 1. Differences in freezing before and after
conditioning between the two groups were analyzed using
a two-way ANOVA, with treatment as the between-
subject factor and time as the within-subject factor.
Freezing during retrieval was quantified as above for ex-
periment 1, and differences in freezing during retrieval
testing between the two groups were analyzed in two
ways. Freezing throughout the whole session was ana-
lyzed using two-tailed unpaired t tests. Freezing during
each 1-min bin of the session was also analyzed using a
two-way ANOVA, with treatment as the between-subject
factor and time as the within-subject factor. Separate anal-
yses were conducted for each brain area. Digitally record-
ed behavior in the open field was analyzed using
Ethovision software (Noldus, Netherlands). The percent-
age time spent in the center of and the total horizontal
distance moved in the open field were determined and
taken as indices of innate fear and locomotor activity,
respectively (Prut and Belzung 2003). Differences in these
behavioral measures between the two groups were ana-
lyzed separately using two-tailed unpaired t tests. Again,
separate analyses were conducted for each brain area. Post
hoc analysis was conducted using the Newman-Keuls test
where indicated. The data are presented in scatter plots,
with the mean ± SEM indicated by horizontal lines and
error bars, respectively, or in line graphs as the mean +
SEM. The level of significance for all comparisons was
set at P < 0.05.
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Results
Experiment 1
SCH23390 impairment of contextual fear conditioning is not
accounted for by state dependency
To determine if disrupted contextual fear conditioning caused
by systemic SCH23390 treatment involves state dependency,
we examined the effects of SCH23390 given before condi-
tioning and/or retrieval testing (n = 8/group). The effects of
SCH23390 given before conditioning on freezing before and
after shock presentations during conditioning are shown in
Fig. 1b. Two-way ANOVA revealed significant main effects
of treatment (F (3, 42) = 6.28, P = 0.0013) and time (F (1, 14) =
754.6, P < 0.0001) but no treatment x time interaction (F (3,
42) = 1.20, P = 0.32). Post hoc analysis indicated that freezing
was significantly increased in the SCH-VEH and SCH-SCH
groups, compared to the VEH-VEH and VEH-SCH groups,
across both time points (i.e., before and after shock presenta-
tions) (P < 0.05). This indicates that SCH23390 increased
freezing acutely during contextual fear conditioning.
The effects of SCH23390 given before conditioning and/or
retrieval on freezing at retrieval are shown in Fig. 1c, d. For
freezing throughout the whole retrieval session (Fig. 1c), one-
way ANOVA revealed a significant main effect of treatment
(F (3, 28) = 9.46, P = 0.0002). Post hoc analysis found no dif-
ference in freezing between the VEH-VEH and VEH-SCH
groups (P > 0.05), indicating that SCH23390 had no effect
on contextual fear retrieval. However, freezing in the SCH-
VEH group was significantly decreased, compared to both the
VEH-VEH and VEH-SCH groups (P < 0.01), suggesting that
SCH23390 impaired contextual fear conditioning.
Importantly, freezing in the SCH-SCH group was also signif-
icantly decreased, compared to both the VEH-VEH and VEH-
SCH groups (P < 0.05). This was confirmed by the more de-
tailed time course analysis (Fig. 1d). Two-way ANOVA re-
vealed a significant main effect of treatment (F (3, 28) = 9.46;
P = 0.0002) but no main effect of time (F (4, 112) = 2.27; P =
0.066) or treatment x time interaction (F (12, 112) = 1.11; P =
0.36). Post hoc analysis indicated that, again, while there was
no difference between the VEH-VEH and VEH-SCH groups
or between the SCH-VEH and SCH-SCH groups (P > 0.05),
freezing in the SCH-VEH and SCH-SCH groups was
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Fig. 2 Representative cannulae tip placements in dmPFC (a), NAc (b), and VH (c), as indicated by the arrows. Schematic representation of cannula tip
placements in dmPFC (d), NAc (e), and VH (f), with the distance (mm) anterior (d, e) or posterior (f) to bregma indicated to the right
Psychopharmacology
significantly decreased, compared to the VEH-VEH and
VEH-SCH groups (P < 0.05). These results indicate that the
effect of SCH23390 on contextual fear conditioning does not
reflect drug effects on state-dependent learning but rather that
SCH23390 disrupts contextual fear encoding.
Experiment 2
SCH23390 infusion into dmPFC, but not NAc or VH, impairs
contextual fear conditioning
SCH23390 was previously shown to impair the acquisi-
tion of contextual fear when infused into the DH or BLA
(Heath et al. 2015). To determine if D1R modulation of
contextual fear conditioning also involves other brain
areas implicated in contextual fear processing, we exam-
ined the effects of infusing SCH23390 into dmPFC, NAc,
or VH on the acquisition of contextual fear. The effect of
SCH23390 infusion into dmPFC before conditioning on
freezing before and after shock presentations during con-
ditioning is shown in Fig. 3b. Two-way ANOVA revealed
a significant main effect of time (F (1, 30) = 1493,
P < 0.0001) but no main effect of treatment (F (1, 30) =
3.12, P = 0.087) or treatment x time interaction (F (1,
30) = 1.88, P = 0.18). This indicates that SCH23390 (n =
16) had no effect on freezing, compared to vehicle (n =
16), during conditioning. The effect of intra-dmPFC infu-
sion of SCH23390 before conditioning on freezing during
retrieval is shown in Fig. 3c, d. SCH23390 significantly
decreased freezing over the entire retrieval session, com-
pared to vehicle (t (30) = 2.27, P = 0.031), indicating that
SCH23390 infusion into dmPFC disrupted contextual fear
conditioning (Fig. 3c). The time course analysis showed
that this effect of SCH23390 was driven by decreased
freezing during later retrieval (Fig. 3d). Two-way
ANOVA revealed significant main effects of treatment
(F (1, 30) = 5.13; P = 0.031) and time (F (4, 120) = 21.04;
P < 0.0001), and a significant treatment x time interaction
(F (4, 120) = 4.67; P = 0.0015). Post hoc analysis showed
that intra-dmPFC SCH23390 infusion significantly de-
creased freezing during the fourth and fifth minute of
the retrieval session (P < 0.01).
The effect of infusing SCH23390 into the NAc before
conditioning on freezing before and after shock presenta-
tions during conditioning is shown in Fig. 3e. Two-way
ANOVA revealed a significant main effect of time (F (1,
19) = 381.1, P < 0.0001) but no main effect of treatment (F
(1, 19) = 1.11, P = 0.30) or treatment x time interaction (F
(1, 19) = 0.36, P = 0.56). This indicates that there was no
effect of SCH23390 (n = 10), compared to vehicle (n = 9),
on freezing during conditioning. The effect of SCH23390
infusion into the NAc before conditioning on freezing at
retrieval is shown in Fig. 3f, g. SCH23390 also had no
effect on freezing, compared to vehicle (t (17) = 0.54, P =
0.60), over the whole retrieval session (Fig. 3f). This was
confirmed by the time course analysis (Fig. 3g). Two-way
ANOVA revealed a significant main effect of time (F (4,
68) = 9.64; P < 0.0001) but no main effect of treatment (F
(1, 17) = 0.29; P = 0.60) or treatment x time interaction (F
(4, 68) = 1.08; P = 0.38). These results indicate that
SCH23390 infusion into the NAc did not affect contextual
fear conditioning.
The effect of infusing SCH23390 into the VH before
conditioning on freezing before and after shock presenta-
tions during conditioning is shown in Fig. 3h. Again, two-
way ANOVA revealed a significant main effect of time (F
(1, 15) = 158.6, P < 0.0001) but no main effect of treatment
(F (1, 15) = 0.64, P = 0.44) or treatment x time interaction
(F (1, 15) = 1.44, P = 0.25). This indicates that there was no
effect of SCH23390 (n = 10), compared to vehicle (n = 7),
on freezing during conditioning. The effect of intra-VH
SCH23390 infusion before conditioning on freezing dur-
ing retrieval is shown in Fig. 3i, j. SCH23390 also had no
effect on freezing, compared to vehicle (t (15) = 0.31, P =
0.76), over the entire retrieval session (Fig. 3i). This was
confirmed by the time course analysis (Fig. 3j). The two-
way ANOVA revealed a significant main effect of time (F
(4, 60) = 10.82; P < 0.0001) but no main effect of treatment
(F (1, 15) = 0.093; P = 0.76) or treatment x time interaction
(F (4, 68) = 1.18; P = 0.33). These results indicate that
SCH23390 infusion into the VH also had no effect on
contextual fear conditioning.
SCH23390 infusion into NAc, but not dmPFC or VH, reduces
locomotor activity in the open field
We also examined the effects of infusing SCH23390 into
dmPFC, NAc, or VH on locomotor activity and innate
fear during open-field testing to determine if the effects
of systemic SCH23390 treatment reported in previous
studies involve these areas. The effects of SCH23390 in-
fusion into dmPFC on behavior in the open-field test are
shown in Fig. 4a, b. Compared to vehicle (n = 14),
SCH23390 (n = 18) had no effect on the percentage of
time spent in the center (t (30) = 0.26, P = 0.79; Fig. 4a)
Fig. 3 SCH23390 infusion into dmPFC, but not NAc or VH, impairs
contextual fear conditioning. a Schematic representation of the
experimental design used. b Infusion of SCH23390 into dmPFC before
conditioning had no effect on freezing during conditioning. c SCH23390
infused into dmPFC before conditioning decreased freezing during
retrieval, compared to vehicle, over the whole session (*P < 0.05). d
This effect of intra-dmPFC SCH23990 infusion was due to a decrease
in freezing in the fourth and fifth minute of the retrieval session
(**P < 0.01). SCH23390 infusion into NAc before conditioning had no
effect on freezing during conditioning (e) or retrieval (f, g). SCH23390
infused into the VH was also without effect on freezing during condition-
ing (h) or retrieval (i, j)
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or the distance moved (t (30) = 0.58, P = 0.57; Fig. 4b) in
the open field. The effects of infusing SCH23390 into the
NAc on behavior during open-field testing are shown in
Fig. 4c, d. SCH23390 (n = 10) had no significant effect on
the percentage of time spent in the center (t (17) = 1.95,
P = 0.067; Fig. 4c) but did significantly decrease the
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distance moved (t (17) = 2.68, P = 0.016; Fig. 4d) in the
open field, compared to vehicle (n = 9). The effects of
intra-VH infusion of SCH23390 on behavior in the
open-field test are shown in Fig. 4e, f. There were no
effects of SCH23390 (n = 10) on the percentage of time
spent in the center (t (15) = 1.20, P = 0.25, Fig. 4e) or the
distance moved (t (15) = 1.44, P = 0.17; Fig. 4f) during
open-field testing, compared to vehicle (n = 7). These re-
sults indicate that, while SCH23390 does not act in any of
these areas to regulate innate fear, the NAc is a site of
action for the modulatory effects of this drug on locomo-
tor activity.
Discussion
This study investigated the role of D1Rs in modulating
contextual fear conditioning in two ways. First, we deter-
mined if the impairing effect of systemic SCH23390 ad-
ministration on the acquisition of contextual fear reported
previously involves state dependency. In experiment 1, we
confirmed previous results indicating that SCH23390
treatment disrupts contextual fear conditioning but not
its retrieval. We also extended these findings by showing
that its effect on the acquisition of contextual fear was not
attributable to a state-dependent effect of this drug, given
that SCH23390 administered before both learning and
memory testing still resulted in impaired contextual fear
conditioning. Second, we further characterized the neural
substrates involved in mediating D1R regulation of con-
textual fear conditioning by examining the effect of infus-
ing SCH23390 into VH, dmPFC, or NAc on the acquisi-
tion of contextual fear. In experiment 2, we found that
SCH23390 infusion into dmPFC, but not VH or NAc,
disrupted the acquisition of contextual fear, indicating that
D1R signalling in dmPFC is involved in regulating con-
textual fear conditioning. We also showed that SCH23390
infused into the NAc, but not VH or dmPFC, reduced
locomotor activity in the open-field test, confirming pre-
vious findings indicating that D1Rs in NAc play a role in
modulating locomotion.
Our results showing that systemic SCH23390 treatment
impaired the acquisition but not retrieval of contextual fear
confirm previous findings (Inoue et al. 2000; Bai et al. 2009;
Calzavara et al. 2009; Heath et al. 2015). SCH23390 en-
hanced freezing during conditioning, whereas it may have
been expected that impaired acquisition would be associat-
ed with decreased freezing after shock presentations during
conditioning. This finding is difficult to interpret though,
given that SCH23390 also reduces locomotor activity
acutely (Bruhwyler et al. 1991; Heath et al. 2015), which
might resemble enhanced freezing. However, during re-
trieval, SCH23390 had no significant effect on freezing
acutely. One possible explanation for this discrepancy is
that novelty, which is associated with a dopamine-
dependent increase in locomotion (Blanchard et al. 2009),
was a factor during conditioning but not at retrieval. It is
worth noting that, while systemic SCH23390 administra-
tion did not affect contextual fear retrieval, local infusions
of this drug have been shown to disrupt the retrieval of
different types of fear memory (Lamont and Kokkinidis
1998; Nader and LeDoux 1999), including contextual fear
(Albrechet-Souza et al. 2013), possibly indicating opposing
effects in different brain areas resulting in no net effect when
SCH23390 is given systemically.
Our results also provide evidence that the disruptive effect
of SCH23390 on the acquisition of contextual fear does not
Fig. 4 SCH23390 infusion into NAc, but not dmPFC or VH, reduces
locomotor activity in the open-field test. SCH23390 infusion into dmPFC
had no effect on innate fear, measured as the time spent in the center (a),
or locomotor activity, measured as the horizontal distance moved (b), in
the open-field test. Infusing SCH23390 into NAc had no significant effect
on innate fear (c) but it did decrease locomotor activity (d), compared to
vehicle (*P < 0.05). SCH23390 infused into VH had no effect on innate
fear (e) or locomotor activity (f)
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reflect state dependency. Previous studies did not examine the
effects of SCH23390 on contextual fear conditioning with
drug given before both conditioning and retrieval; therefore,
the reported effects of SCH23390 may have been due to a
mismatch between the drug-induced internal state during con-
ditioning and retrieval. If SCH23390 given before condition-
ing and retrieval had no effect on freezing at retrieval, then this
would support the interpretation that SCH23390-induced im-
pairment of contextual fear conditioning reflected drug effects
on state-dependent learning. Alternatively, if SCH23390 giv-
en before conditioning and retrieval results in reduced freez-
ing at retrieval, as we found in the present study, then this
provides evidence that the impairing effect of SCH23390 on
contextual fear conditioning cannot be accounted for by state
dependency. This finding is congruent with previous studies
showing that state-dependent drug effects did not explain the
disruptive effects of local infusions of dopamine receptor an-
tagonists on spatial learning or cued fear retrieval (Pezze et al.
2003; O’Carroll et al. 2006).
In terms of the brain areas involved in mediating its effect,
we found that infusing SCH23390 into dmPFC impaired con-
textual fear conditioning. This indicates that D1Rs in this area
contribute to the acquisition of contextual fear, which is in
general agreement with recent studies showing that D1R acti-
vation in dmPFC facilitates the encoding of fear memory in-
volving weaker contextual cues (Pezze et al. 2016; Castillo
Díaz et al. 2017). How D1R signalling in dmPFC modulates
contextual fear conditioning remains unclear, but there are
several possibilities. D1Rs in this area are crucial for atten-
tional processing (Dalley et al. 2004), suggesting that their
antagonism may impair the acquisition of contextual fear by
disrupting attention to contextual cues during conditioning.
D1R signalling in dmPFC may also modulate functional in-
teractions between dmPFC and hippocampus. VH stimulation
increases dopamine release in dmPFC (Peleg-Raibstein et al.
2005). Moreover, D1R signalling modulates synchronized
neural activity and long-term potentiation in the
hippocampo-prefrontal pathway (Jay et al. 2004; Werlen and
Jones 2015). This suggests that local blockade of D1Rs may
interfere with synaptic plasticity in dmPFC related to contex-
tual encoding conveyed by the hippocampus. The dmPFC is
also important for mediating the affective component of pain
processing, which is thought to involve input from BLA
(Neugebauer 2015). Although systemic SCH23390 adminis-
tration has no effect on shock sensitivity (Inoue et al. 2000;
Heath et al. 2015), dopamine in dmPFC does regulate pain
processing, and synaptic plasticity in the amygdala-prefrontal
pathway is modulated by dopamine (Lopez-Avila et al. 2004;
Onozawa et al. 2011). Therefore, blocking D1Rs in this area
might also disrupt affective aspects of pain processing related
to the US conveyed by BLA. Further research is needed to
determine the precise role of dmPFC D1R signalling in con-
textual fear conditioning.
In contrast to dmPFC, SCH23390 infusions into the NAc
had no effect on the acquisition of contextual fear, although
they did have a clear behavioral effect in the open-field test
(see below). Both the hippocampus and BLA project to NAc,
making this area well-placed for integrating contextual and
associative aspects of contextual fear conditioning
(McDonald 1991; Thierry et al. 2000). Excitotoxic lesions or
temporary inactivation of the NAc impairs the acquisition of
contextual fear (Haralambous and Westbrook 1999; Levita
et al. 2002a). Dopamine and D1R signalling in this area have
also been implicated in contextual fear conditioning and its
retrieval in some (Saulskaya and Marsden 1995; Pezze et al.
2001; Martinez et al. 2008; Albrechet-Souza et al. 2013;
Ikegami et al. 2014), but not all (Levita et al. 2002b), previous
studies. Differences in methodological procedures (e.g., fore-
ground vs background contextual cues) and anatomical spec-
ificity (e.g., NAc core vs shell subregions and rostral vs caudal
NAc) between the studies may account for some of these
apparent discrepancies (Levita et al. 2002b). Previous studies
have suggested that the caudal NAc core and its dopamine
innervation are involved in contextual fear conditioning
(Levita et al. 2002a, b). Our infusion sites ended up being
located more rostrally, but they showed considerable anatom-
ical heterogeneity in terms of their spread across both NAc
core and shell. However, it might be expected that diffusion of
drug occurred to some extent between NAc shell and the
overlying core. In support of this idea, Haralambous and
Westbrook (1999) found that neuronal inactivation with infu-
sions of the sodium channel inhibitor bupivicaine into NAc
had a similar disruptive effect on contextual fear conditioning
as lesions to the caudal NAc core; however, their infusions
were spread across the rostrocaudal extent of both NAc core
and shell, albeit using a greater infusion volume than we used
here. Nevertheless, it is possible that we may have observed
an effect of SCH23390 in the present study using drug infu-
sions with more anatomical selectively.
Infusing SCH23390 into the VHwas also without effect on
the acquisition of contextual fear. This area receives input
from the DH and projects to the BLA (Pitkanen et al. 2000),
thereby providing a link between brain regions that are pivotal
for contextual fear conditioning. Lesions, temporary inactiva-
tion, and NMDA receptor antagonism in VH impair this form
of aversive learning (Bast et al. 2001; Sutherland et al. 2008;
Czerniawski et al. 2012; Zhang et al. 2001, 2014). Taken
together with our results, these findings indicate that neuronal
activity and synaptic plasticity in this area are necessary for
contextual fear conditioning but that local D1R signallingmay
not be required for this process.
Infusing SCH23390 into dmPFC did not affect the
amount of time spent in the center of the open field, in-
dicating that D1R signalling in this area may play differ-
ent roles in regulating innate fear and contextual fear
learning. This lack of effect is consistent with the results
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of previous studies showing no effect of dmPFC inactiva-
tion on innate fear (Corcoran and Quirk 2007; Stevenson
2011). We also found that SCH23390 infused into dmPFC
had no effect on locomotor activity, which has also been
shown previously (Barros et al. 2001; Shah et al. 2004;
Hall et al. 2009). Similarly, SCH23390 infusion into VH
had no effect on innate fear or locomotion during open-
field testing, confirming previous findings (Giménez-Llort
et al. 2002; Andrzejewski et al. 2006; Zarrindast et al.
2010). Lesions or inactivation of VH reduces innate fear
in the elevated plus maze (Kjelstrup et al. 2002; Trent and
Menard 2010), but our results suggest that D1Rs in this
area are not involved in regulating innate fear. In the NAc,
we found that SCH23390 reduced locomotion but had no
significant effect on innate fear in the open-field test.
Again, our results agree with previous studies showing
D1R signalling in this area modulates locomotor activity
but not innate fear (Dreher and Jackson 1989; Ahmadi
et al. 2013).
In conclusion, our results confirm previous findings show-
ing that SCH23390 impairs the acquisition of contextual fear
and extends them by showing that this effect is not due to this
drug causing effects on state-dependent learning. Our results
also provide evidence that D1R regulation of contextual fear
conditioning is mediated at least in part by dmPFC, adding to
other brain areas (i.e., DH, BLA, and lateral habenula) recent-
ly shown to be involved in this process (Heath et al. 2015;
Chan et al. 2017). We found that SCH23390 had a greater
impairing effect on contextual fear conditioning when giv-
en systemically than when it was infused locally into
dmPFC, which is perhaps not surprising if other brain re-
gions are also involved in mediating its effect. Moreover,
the acute effect of SCH23390 on freezing during condi-
tioning when given systemically was not observed with
local infusions into dmPFC, NAc, or VH. This suggests
that, again, more than one of these brain areas might be
required, or that other brain areas mediate this effect of
SCH23390. More generally, this study contributes to a
growing body of research demonstrating that dopamine is
important for regulating contextual fear processing (Pezze
and Feldon 2004; Brandão et al. 2015). Future studies in-
vestigating D1R modulation of functional interactions and
synaptic plasticity in the DH-BLA-dmPFC network will
help to further elucidate the neurochemical and neural cir-
cuit basis of contextual fear conditioning.
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